Analysts have clear opinions on ALC.
There are 5 analysts on the Wall offering 12 month price targets for Alcon in the last 3 months. The average price target is $65.82 with a high forecast of $70.00 and a low forecast of $59.47. The average price target represents a 5.48% increase from the last price of $62.40.
Alcon, Inc. (ALC) is followed by 5 analysts on the street.
John Staszak from Argus Research rates it a Hold.
Similarly, 2 months ago David Lewis of Morgan Stanley Reiterated a Buy with a target of $70.00.
The consensus on the street is null.
What does Alcon, Inc.(ALC) do ?
Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through Surgical and Vision Care segments. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Hünenberg, Switzerland.
Alcon, Inc. (ALC) Insider Trades